Canada’s health security depends on increased support for high-risk, high-reward scientific research

Growing the biotech industry would accelerate our transition to a knowledge-based economy, and provide new drivers of economic prosperity.

Innovation Minister François-Philippe Champagne oversees the government's science and innovation file. The government must lower the barriers to startup creation in the biomedical sector.The Hill Times photograph by Andrew Meade

Opinion

BY SHANA KELLEY AND PIETER CULLIS

March 10, 2021

The COVID-19 pandemic has exposed the fact that Canada lacks biopharmaceutical and vaccine manufacturing capacity. At the same time, it has highlighted Canada’s strengths in biopharmaceutical innovation. A critical component of the Pfizer/BioNTech COVID-19 vaccine �...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy